ANGELA CHANDLER: Open Payments
NPI 1144722000 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 22 payments from 9 companies in 2025. Trend: 2023 $617 · 2024 $304 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $136 |
| AstraZeneca Pharmaceuticals LP | 3 | $71 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $44 |
| Pharming Healthcare, Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| GENZYME CORPORATION | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
Products named: DUPIXENT, AIRSUPRA, NEFFY, RUCONEST, NUCALA, EOHILIA, XHANCE.
Industry payments across FL — which companies pay providers there.
